
Sign up to save your podcasts
Or
Failure to initiate an SGLT2i to an eligible HFrEF patient exposes the patient to higher risk of early post-discharge death and readmission, and the real risk that the medication never gets prescribed at all.
In this interview, Stephen J. Greene, MD and Christopher B. Granger MD, FACC, with Ioannis Mastoris, MD, MPH, discuss In-Hospital Initiation of Sodium Glucose Cotransporter-2 Inhibitors for Heart Failure with Reduced Ejection Fraction.
Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
3.8
4747 ratings
Failure to initiate an SGLT2i to an eligible HFrEF patient exposes the patient to higher risk of early post-discharge death and readmission, and the real risk that the medication never gets prescribed at all.
In this interview, Stephen J. Greene, MD and Christopher B. Granger MD, FACC, with Ioannis Mastoris, MD, MPH, discuss In-Hospital Initiation of Sodium Glucose Cotransporter-2 Inhibitors for Heart Failure with Reduced Ejection Fraction.
Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
130 Listeners
319 Listeners
160 Listeners
862 Listeners
494 Listeners
22 Listeners
32 Listeners
87 Listeners
135 Listeners
1,082 Listeners
39 Listeners
186 Listeners
415 Listeners
35 Listeners
135 Listeners